pf-00489791
Showing 1 - 5 of 5
Hypertension Trial in United States (, PF-00489791)
Completed
- Hypertension
- placebo
- PF-00489791
-
Los Angeles, California
- +19 more
Sep 13, 2021
Raynaud's Disease, Peripheral Vascular Disease Trial in Worldwide (PF-00489791)
Completed
- Raynaud's Disease
- Peripheral Vascular Disease
- PF-00489791
-
Redwood City, California
- +54 more
Apr 16, 2018
Diabetic Nephropathies Trial in Worldwide (PF-00489791, Placebo)
Completed
- Diabetic Nephropathies
- PF-00489791
- Placebo
-
Huntsville, Alabama
- +159 more
Feb 18, 2019
Hypertension, Pulmonary Trial in Worldwide (PF-00489791, , sildenafil)
Terminated
- Hypertension, Pulmonary
- PF-00489791
- +2 more
-
Phoenix, Arizona
- +24 more
Sep 20, 2017
Healthy Volunteers Trial in Brussels (itraconazole, diltiazem, SR verapamil)
Completed
- Healthy Volunteers
- itraconazole
- +3 more
-
Brussels, BelgiumPfizer Clinical Research Unit
Jul 28, 2016